Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.39
(-0.41%)
CNY 14.39
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.36 Billion | 1.22 Billion | 677.51 Million | 400.39 Million | 554.16 Million | 264.78 Million |
| Net Income | 1.03 Billion | 920.55 Million | 634.15 Million | 379.88 Million | 236.96 Million | 155.92 Million |
| Depreciation & Amortization | 383.67 Million | 348.19 Million | 292.07 Million | 252.31 Million | 190.93 Million | 175.54 Million |
| Deferred income taxes | 18.89 Million | 7.49 Million | 22.96 Million | 25.92 Million | 15.91 Million | 4.9 Million |
| Stock-based compensation | 19.12 Million | 34.97 Million | 20 Million | 7.14 Million | -3.28 Million | 14.02 Million |
| Change in working capital | -206.32 Million | -100.45 Million | -307.51 Million | -318.75 Million | 91.69 Million | -130.98 Million |
| Other non-cash items | 1.12 Billion | 15.02 Million | 15.83 Million | 53.87 Million | 21.93 Million | 64.29 Million |
| Investing Cash Flow | -1.05 Billion | -738.41 Million | -765.43 Million | -210.53 Million | -661.71 Million | -280.18 Million |
| Investments in PPE | -929.44 Million | -713.78 Million | -579.88 Million | -315.72 Million | -320.45 Million | -230.66 Million |
| Acquisitions | -109.34 Million | -31.28 Million | 8.25 Million | 43.01 Million | -64.9 Million | 2.76 Million |
| Investment purchases | -41.26 Million | -14.8 Million | -70.25 Million | -13.32 Million | -22.02 Million | -23.41 Million |
| Sales/Maturities of investments | -1.00 | 23.58 Million | 60.28 Million | 8 Million | 1.1 Million | 91.11 Million |
| Other Investing Activities | 23.24 Million | -2.12 Million | -183.84 Million | 67.5 Million | -255.44 Million | -26.11 Million |
| Financing Cash Flow | 2.1 Billion | -608.96 Million | 582.42 Million | -116.12 Million | 111.22 Million | -63.52 Million |
| Debt repayment | -62.56 Million | -1.28 Billion | -1.68 Billion | -1.76 Billion | -1.43 Billion | -811.1 Million |
| Dividends payments | -358.64 Million | -208.57 Million | -166.27 Million | -160.66 Million | -161.17 Million | -93.54 Million |
| Common Stock Repurchased | -65.28 Million | -53.93 Million | -8.22 Million | -246.15 Million | -534.24 Thousand | -1.38 Million |
| Common Stock Issuance | - | 53.93 Million | 8.22 Million | 246.15 Million | 534.24 Thousand | - |
| Other Financing Activities | 2.46 Billion | 912.19 Million | 2.45 Billion | 1.85 Billion | 1.71 Billion | 841.13 Million |
| Accounts receivables | -228.54 Million | 84.28 Million | -312.33 Million | -185.56 Million | 38.81 Million | -195.93 Million |
| Accounts payables | 14.45 Million | 194.43 Million | 492.06 Million | 205.44 Million | 57.7 Million | 67.95 Million |
| Inventory | -9.38 Million | -386.67 Million | -510.2 Million | -364.55 Million | -20.74 Million | -7.9 Million |
| Other working capital | 17.14 Million | 7.49 Million | 22.96 Million | 25.92 Million | 15.91 Million | -123.07 Million |
| Cash at beginning of period | 1.09 Billion | 726.74 Million | 254.82 Million | 232.58 Million | 232.77 Million | 297.67 Million |
| Cash at end of period | 3.2 Billion | 662.75 Million | 726.74 Million | 254.82 Million | 232.58 Million | 232.77 Million |
| Capital Expenditure | -929.44 Million | -713.78 Million | -579.88 Million | -315.72 Million | -320.45 Million | -230.66 Million |
| Effect of forex changes on cash | 7.6 Million | 57.61 Million | -22.59 Million | -51.49 Million | -3.86 Million | 14.02 Million |
| Net cash flow / Change in cash | 2.11 Billion | -63.98 Million | 471.91 Million | 22.24 Million | -196.61 Thousand | -64.89 Million |
| Free Cash Flow | 430.88 Million | 511.99 Million | 97.63 Million | 84.66 Million | 233.71 Million | 34.12 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 155.88 Million | 238.22 Million | 236.75 Million | 66.48 Million | 1.03 Billion | 345.04 Million |
| Depreciation & Amortization | - | 100.38 Million | 100.38 Million | 98.15 Million | 383.67 Million | -183.24 Million |
| Deferred income taxes | - | - | - | 201.65 Million | 18.89 Million | 84.27 Million |
| Stock-based compensation | - | - | - | 19.12 Million | 19.12 Million | -9.31 Million |
| Change in working capital | - | - | - | -220.78 Million | -206.32 Million | 108.28 Million |
| Other non-cash items | 178.61 Million | 318.14 Million | -373.22 Million | 50.41 Million | 1.12 Billion | 81.35 Million |
| Investing Cash Flow | -252.63 Million | -260.79 Million | -233.7 Million | -305.44 Million | -1.05 Billion | -216.76 Million |
| Investments in PPE | -263.48 Million | -246.02 Million | -233.98 Million | -317.74 Million | -929.44 Million | -206.29 Million |
| Acquisitions | 476.2 Thousand | 220.67 Thousand | 282.18 Thousand | -3.54 Million | -109.34 Million | 453.84 Thousand |
| Investment purchases | - | -15 Million | - | -7.4 Million | -41.26 Million | -10.91 Million |
| Sales/Maturities of investments | 10.33 Million | - | - | -1.00 | -1.00 | -453.84 Thousand |
| Other Investing Activities | 10.84 Million | -14.77 Million | 282.18 Thousand | 23.24 Million | 23.24 Million | 453.84 Thousand |
| Financing Cash Flow | -394.98 Million | -1.03 Billion | 952.5 Million | -609.68 Million | 2.1 Billion | -384.23 Million |
| Debt repayment | -55.1 Million | -1.26 Billion | -1.29 Billion | -591 Million | -62.56 Million | -519 Million |
| Dividends payments | -446.89 Million | -5.59 Million | -7.41 Million | -358.64 Million | -358.64 Million | -366.79 Million |
| Common Stock Repurchased | 101.73 Million | 238.24 Million | -339.97 Million | -10.17 Million | -65.28 Million | 4236.95 |
| Common Stock Issuance | - | - | - | - | - | -4236.00 |
| Other Financing Activities | -3.2 Million | -5.59 Million | -7.41 Million | 350.14 Million | 2.46 Billion | 501.56 Million |
| Accounts receivables | - | - | - | -228.54 Million | -228.54 Million | 316.18 Million |
| Accounts payables | - | - | - | - | 14.45 Million | 14.57 Million |
| Inventory | - | - | - | -9.38 Million | -9.38 Million | -207.89 Million |
| Other working capital | - | - | - | 17.14 Million | 17.14 Million | -14.57 Million |
| Cash at beginning of period | 2.82 Billion | 4.05 Billion | 3.2 Billion | 3.91 Billion | 1.09 Billion | 3.96 Billion |
| Cash at end of period | 2.49 Billion | 2.95 Billion | 4.05 Billion | 3.2 Billion | 3.2 Billion | 3.79 Billion |
| Capital Expenditure | -263.48 Million | -246.02 Million | -233.98 Million | -317.74 Million | -929.44 Million | -206.29 Million |
| Effect of forex changes on cash | -12.26 Million | 4.67 Million | 700.48 Thousand | -13.87 Million | 7.6 Million | 702.01 Thousand |
| Net cash flow / Change in cash | -325.37 Million | -1.1 Billion | 853.04 Million | -712.34 Million | 2.11 Billion | -173.88 Million |
| Free Cash Flow | 71.02 Million | 209.96 Million | -370.45 Million | -102.69 Million | 430.88 Million | 220.1 Million |
9534
SIMH3
CAVEN
9885
5227
PSNYW